After protests, HCFA requires coverage of anti-wasting drug. Health Care Financing Administration.
D013006:Growth Hormone / Q000627:therapeutic use*; D019247:HIV Wasting Syndrome / Q000188:drug therapy*; D019382:Human Growth Hormone; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence*; D008484:Medicaid; D013781:Texas; D014481:United States
D019382:Human Growth Hormone; D013006:Growth Hormone